Tesamorelin 10MG

Tesamorelin is a synthetic peptide with a defined 44-amino-acid sequence and a structural modification in the N-terminal region. It is utilized in controlled laboratory environments for analytical, biochemical, and molecular research involving peptide characterization and experimental evaluation. The research material may be supplied in lyophilized form, with product-specific characteristics documented through the applicable batch information and analytical records.

Research Applications:

Tesamorelin may be utilized in controlled laboratory research settings for applications such as:

• Analytical characterization of peptide structure and sequence properties
• Evaluation of peptide stability and degradation under defined experimental conditions
• Investigation of receptor-binding and molecular interaction behavior in biochemical assay systems
• Examination of peptide activity within appropriately designed in vitro research models

Storage and Handling:

• Store according to the temperature conditions specified in the batch-specific product documentation.
• Following laboratory preparation, maintain under validated conditions appropriate to the specific research protocol.
• Use appropriate laboratory handling procedures to minimize contamination and preserve material integrity.

Product Specifications:

• Purity: Refer to batch-specific HPLC results or Certificate of Analysis
• Appearance: Lyophilized powder, where applicable to the supplied research preparation
• Solubility: Refer to batch-specific technical documentation and validated laboratory procedures

Compliance Notice:

Tesamorelin supplied by Steady Labs is FOR RESEARCH USE ONLY and is not offered for human or veterinary use. The Steady Labs research material is intended exclusively for controlled laboratory, analytical, and in vitro research activities and is not being offered for diagnostic, therapeutic, or clinical application.

Important compliance point: Tesamorelin itself is associated with FDA-approved prescription products, so I intentionally did not write “Tesamorelin has not been evaluated by the FDA.” That statement would be inaccurate. The FDA describes tesamorelin as a synthetic GRF analogue and provides its chemical characterization in approved labeling.